Page last updated: 2024-08-23

mifepristone and gdc 0941

mifepristone has been researched along with gdc 0941 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allen, V; Blackaby, W; Chan, GKY; Chang, JH; Chiang, PC; Del Rosario, G; Diène, C; Do, S; Drummond, J; Ebens, AJ; Fan, E; Harstad, EB; Hodges, A; Hu, H; Jia, W; Kofie, W; Kolesnikov, A; Ly, J; Lyssikatos, JP; Matteucci, M; Moffat, JG; Munugalavadla, V; Murray, J; Nash, D; Noland, CL; Ross, L; Rouse, C; Sharpe, A; Slaga, D; Sun, M; Tsui, V; Wallweber, H; Wang, X; Yu, SF	1

Other Studies

1 other study(ies) available for mifepristone and gdc 0941

Article	Year
Optimization of Pan-Pim Kinase Activity and Oral Bioavailability Leading to Diaminopyrazole (GDC-0339) for the Treatment of Multiple Myeloma. Journal of medicinal chemistry, 2019, 02-28, Volume: 62, Issue:4 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dogs; Female; Humans; Macaca fascicularis; Madin Darby Canine Kidney Cells; Male; Mice, SCID; Molecular Structure; Multiple Myeloma; Protein Binding; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Pyrazoles; Rats, Sprague-Dawley; Structure-Activity Relationship; Xenograft Model Antitumor Assays	2019

Article

Year

Optimization of Pan-Pim Kinase Activity and Oral Bioavailability Leading to Diaminopyrazole (GDC-0339) for the Treatment of Multiple Myeloma.

Journal of medicinal chemistry, 2019, 02-28, Volume: 62, Issue:4

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dogs; Female; Humans; Macaca fascicularis; Madin Darby Canine Kidney Cells; Male; Mice, SCID; Molecular Structure; Multiple Myeloma; Protein Binding; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Pyrazoles; Rats, Sprague-Dawley; Structure-Activity Relationship; Xenograft Model Antitumor Assays

2019